481 results found

Astellas Named a PM360 Trailblazer 2018 "Company of the Year"

Astellas was recognized as the silver winner for "Company of the Year" in the Pharmaceutical and Biotech industries at the PM360 Trailblazer 2018 Awards ceremony on Sept. 13. In addition,...

More than 800 Astellas Employees Volunteer for 16 Community Organizations as Part of Ninth Annual Changing Tomorrow Day

More than 800 Astellas employees joined together across four countries to help their communities and volunteer at 16 local nonprofit organizations. The effort is part of Changing Tomorrow Day...

Astellas Announces Launch of "What's Next Sweepstakes" with Laila Ali

Astellas Pharma US, Inc., announced today the launch of the "What's Next Sweepstakes," sponsored by Myrbetriq® (mirabegron). Fans age 18 and older can enter for a chance to win a trip for two to...

Astellas Appoints Shontelle Dodson to Senior Vice President Health Systems

Astellas today announced that Shontelle Dodson, Pharm.D, has been appointed to senior vice president, Health Systems. In this role, Shontelle will assume overall responsibility for the Health...

Astellas Promotes Rodrigo Fernandez to Vice President, Latin America

Astellas today announced that Rodrigo Fernandez has been promoted to vice president, Latin America, based in Northbrook and reporting to Percival Barretto-Ko, president, Astellas Americas....

Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced amendments to the protocols for two registrational Phase 3...

Astellas Promotes David Abbott to National Vice President Key Account Management

Astellas today announced that David Abbott has been promoted to national vice president Key Account Management (KAM). Abbott's previous role was senior director of Key Account Management for the...

Astellas Announces Acquisition of Quethera

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., "Astellas") and Quethera Limited (CEO: Peter Widdowson, Ph.D., "Quethera") today announced that Astellas has acquired...

Astellas Statement on U.S. Drug Pricing

For the remainder of 2018, Astellas will not increase any of the company’s drug prices in the United States. Astellas believes that the price of medicines should be a fair reflection of the...